B. Braun Medical debuts new Heparin Sodium Injections, offering the largest U.S. premixed line with enhanced barcodes and ...

In its latest regulatory update for June 2025, the Central Drugs Standard Control Organisation (CDSCO) has flagged a total of ...

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium Injections into the U.S. market, expanding its portfolio ...

This study aimed to examine whether there was an association between cumulative fluid balance and serum sodium and chloride levels on the third and seventh days of hospitalization in the intensive ...

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...